公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	Omarigliptin Protects the Integrity of the Blood–Brain Barrier After Intracerebral Hemorrhage in Mice	4	Journal of Inflammation Research
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	CCDC134 enhances ovarian reserve function and angiogenesis by directly interacting with INHA in a mouse model of premature ovarian insufficiency.	8.100	Apoptosis
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	Electroacupuncture reduces blood glucose by regulating intestinal flora in type 2 diabetic mice	5	Journal of Diabetes
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	Lycium barbarum polysaccharide alleviates dextran sodium sulfate-induced inflammatory bowel disease by regulating M1/M2 macrophage polarization via …	6	Frontiers in Pharmacology
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	NLRP3 in tumor-associated macrophages predicts a poor prognosis and promotes tumor growth in head and neck squamous cell carcinoma	6	CANCER IMMUNOL IMMUN
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	MBD2 facilitates tumor metastasis by mitigating DDB2 expression	9	Cell Death & Disease
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	Activation of A4B adenosine receptor protects against demyelination in a mouse model of schizophrenia	2	Exp Ther Med
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	Decreased IL‑37 expression in hepatocellular carcinoma tissues and liver cancer cell lines	2	Bitmap
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	Immunocolocalization of Interferon Regulatory Factory 5 with Tumor Necrosis Factor Receptor–associated Factor 6 and AKT2 in Human Apical Periodontitis	4	Journal of Endodontics
A23420	山羊抗兔IgG二抗，橙红色DyLight 594荧光标记	The ACE2-Ang-(1‑7)-Mas Axis Modulates M1/M2 Macrophage Polarization to Relieve CLP-Induced Inflammation via TLR4-Mediated NF-кb and MAPK	5	J Inflamm Res

首页上一页 227 228 229 230 231 232 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部